Stock report · Symbol changed · NYSE American
NeoStem, Inc. (NBS)
Symbol changed Symbol changed ยท last traded June 5, 2015
NBS is no longer traded under this symbol. NeoStem renamed itself Caladrius Biosciences and began trading under the symbol CLBS on June 8, 2015; the company later became Lisata Therapeutics, which trades as LSTA.
The company now trades as LSTA. See the LSTA stock page for the live quote and chart.
Symbol change details
- Exchange (former)
- NYSE American
- Status
- Symbol changed
- Last trading day
- June 5, 2015
- Reason
- Renamed Caladrius Biosciences (CLBS); now Lisata Therapeutics (LSTA)
- Successor
- Lisata Therapeutics, Inc. (NASDAQ: LSTA)
- New symbol
- LSTA
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New York, New York
About NeoStem, Inc.
NeoStem, Inc. was a cell therapy company that combined its own development programs with a contract business that manufactured cell-based products for other companies. Its pipeline included cell therapies aimed at cardiovascular disease and immune disorders, while its PCT subsidiary provided development and manufacturing services to other cell therapy developers, which gave NeoStem revenue while its own programs were still in clinical trials.
The company was based in New York and its stock traded under the symbol NBS. A key step in its growth was the 2011 acquisition of Progenitor Cell Therapy, which became the contract manufacturing arm. NeoStem also pursued immunotherapy after buying a program for a patient-specific cancer vaccine, and it shifted its strategic emphasis toward immunology and oncology.
To reflect that shift, the company announced plans to change its name to Caladrius Biosciences, Inc. The change took effect for trading on June 8, 2015, when the stock moved from the NBS symbol to CLBS. Caladrius later sold its PCT manufacturing business to Hitachi Chemical and concentrated on regenerative medicine programs for cardiovascular and autoimmune conditions.
In 2022 Caladrius merged with Cend Therapeutics, a developer of a peptide designed to improve delivery of cancer drugs into solid tumors, and the combined company took the name Lisata Therapeutics, Inc., trading under the symbol LSTA. The legal entity that once traded as NBS therefore continues as Lisata.
NeoStem FAQ
What happened to NeoStem stock?
NeoStem renamed itself Caladrius Biosciences and began trading under the symbol CLBS on June 8, 2015; the company later became Lisata Therapeutics, which trades as LSTA.
What is the new ticker symbol for NBS?
NeoStem now trades under the symbol LSTA, as Lisata Therapeutics, Inc. (NASDAQ: LSTA).
Can I still buy NBS stock?
Not under the old symbol. The shares now trade as LSTA, so quotes and charts are listed under LSTA.
NBS no longer trades under this symbol, so there is no live quote or chart on this page. The information on this page is for reference only and is not investment advice; see our disclaimer.